Vertex Pharmaceuticals Stock Is Soaring and at a New All-Time High. Could It Still Be Heading Even Higher?

Live Nation outlines double-digit fan, revenue and AOI growth expectations for 2026 amid Ticketmaster turnaround

NMIH outlines capital return focus with $167M buyback capacity remaining as it expects defaults to trend higher

DexCom rises on Q2 beats, raised 2026 revenue guidance midpoint

Grand Canyon Education outlines path to 80 hybrid locations and plans to open a law school in fall 2027